Baseline immune signature score of tregs × hla-dr+cd4+ t cells × pd1+cd8+ t cells predicts outcome to immunotherapy in cancer patients

HIGHLIGHTS

• who: Rebekka Mispelbaum and collaborators from the Vrije University Brussel, Belgium Fudan University, China have published the paper: Baseline immune signature score of Tregs u00d7 HLA-DR+CD4+ T cells u00d7 PD1+CD8+ T cells predicts outcome to immunotherapy in cancer patients, in the Journal: (JOURNAL)
• what: The aim of this study was to establish immune signature scores of peripheral blood cells predicting success of IT before therapy start in pan-cancer population.
• how: The authors conducted a retrospective clinical study of patients treated with IT for metastatic cancer at a single tertiary . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.